Detalhe da pesquisa
1.
Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL.
Blood
; 129(26): 3419-3427, 2017 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-28424162
2.
Clonal dynamics of Richter transformation in chronic lymphocytic leukemia.
Hematol Oncol
; 42(4): e3282, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38852069
3.
Differential transcriptomic profiling in ibrutinib-naïve versus ibrutinib-resistant Richter syndrome.
Hematol Oncol
; 40(2): 302-306, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34806797
4.
Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression.
Blood
; 115(9): 1755-64, 2010 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-20018914
5.
B cell receptor signaling drives APOBEC3 expression via direct enhancer regulation in chronic lymphocytic leukemia B cells.
Blood Cancer J
; 12(7): 99, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35778390
6.
Mcl-1 expression predicts progression-free survival in chronic lymphocytic leukemia patients treated with pentostatin, cyclophosphamide, and rituximab.
Blood
; 113(3): 535-7, 2009 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19008456
7.
Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome.
Blood Cancer J
; 11(5): 86, 2021 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33972504
8.
Identification of recurrent truncated DDX3X mutations in chronic lymphocytic leukaemia.
Br J Haematol
; 169(3): 445-8, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25382417
9.
Curcumin inhibits prosurvival pathways in chronic lymphocytic leukemia B cells and may overcome their stromal protection in combination with EGCG.
Clin Cancer Res
; 15(4): 1250-8, 2009 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19228728
10.
Bi-directional activation between mesenchymal stem cells and CLL B-cells: implication for CLL disease progression.
Br J Haematol
; 147(4): 471-83, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19751240
11.
Bone marrow hematopoietic dysfunction in untreated chronic lymphocytic leukemia patients.
Leukemia
; 33(3): 638-652, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30291337
12.
Direct and complement dependent cytotoxicity in CLL cells from patients with high-risk early-intermediate stage chronic lymphocytic leukemia (CLL) treated with alemtuzumab and rituximab.
Leuk Res
; 32(12): 1849-56, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18584865
13.
Chronic lymphocytic leukemia cells from ibrutinib treated patients are sensitive to Axl receptor tyrosine kinase inhibitor therapy.
Oncotarget
; 9(98): 37173-37184, 2018 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30647852
14.
Upregulation of AXL and ß-catenin in chronic lymphocytic leukemia cells cultured with bone marrow stroma cells is associated with enhanced drug resistance.
Blood Cancer J
; 11(2): 37, 2021 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33602892
15.
Phase I trial of daily oral Polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia.
J Clin Oncol
; 27(23): 3808-14, 2009 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-19470922
16.
Early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab.
Cancer
; 113(8): 2110-8, 2008 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18759253